Mirum Advances Brelovitug in Phase 3 HDV Trial
Foster City, California, U.S., September 28, 2026 Mirum Pharmaceuticals has announced a major clinical-development milestone for brelovitug, an investigational...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease Regenerative Medicine solid tumors targeted therapy
Foster City, California, U.S., September 28, 2026 Mirum Pharmaceuticals has announced a major clinical-development milestone for brelovitug, an investigational...
Foster City, California & Wilmington, Delaware, September 25, 2026 Mirum Pharmaceuticals and Incyte have announced a major regulatory milestone...
Rockville, Maryland, U.S., September 24, 2026 REGENXBIO Inc. has presented three-year clinical data for surabgene lomparvovec in patients with...
Cambridge, Massachusetts, U.S., September 24, 2026 Atavistik Bio has announced a strategic research collaboration with Roche to discover and...
San Carlos, California, U.S., September 24, 2026 Glycomine, Inc. has announced that the U.S. Food and Drug Administration (FDA)...
Dallas, Texas, September 23, 2026 Nanoscope Therapeutics, Inc. announced plans to present new clinical data from its macular degeneration...
New York, New York, September 23, 2026 Apertura Gene Therapy announced that it will provide Lexeo Therapeutics with access...
Fort Lee, New Jersey, September 23, 2026 Elevar Therapeutics, Inc. has received U.S. Food and Drug Administration (FDA) approval...
Beijing, China, September 24, 2026 InnoCare Pharma has entered into a strategic research collaboration and license agreement with Eli...
San Francisco, California, U.S., and Suzhou, China, September 23, 2026 Innovent Biologics has announced that multiple clinical datasets from...
